/A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)